期刊文献+

抗感染治疗重症急性胰腺炎合并腹腔间隙综合征患者1例的药学分析 被引量:3

Pharmaceutical analysis of antibiotics therapies for one patient with severe acute pancreatitis with abdominal compartment syndrome
原文传递
导出
摘要 本文对1例重症急性胰腺炎合并腹腔间隙综合征患者的抗感染方案进行用药分析。临床药师结合患者临床治疗过程及相关文献,参与制订抗感染治疗方案,实施替考拉宁联合美罗培南的抗感染方案,使得患者症状缓解出院。药师参与重症患者药物治疗方案制定具有积极意义。 Antibiotics therapies in one case of severe acute pancreatitis with abdominal compartment sundrome was analyzed in this article to provide reference for pharmaceutical care. Anti-infective therapeutic regimen consisting of teicoplanin and meropenem was proposed by the clinical pharmacist according to the clinical treatment process and relevant literatures and adopted by the physicians. The patient’s symptoms were relieved and the patient was discharged. It was found that clinical pharmacists have a positive impact on medical therapies of critically ill patients.
作者 谢静文 陈文颖 劳海燕 XIE Jing-wen;CHEN Wen-ying;LAO Hai-yan(Department of Pharmacy the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, China;Department of Pharmacy,Training Rase of Clinical Pharmacist, Guangdong Provincial People's Hospital, Guangzhou 510080,China)
出处 《临床药物治疗杂志》 2019年第3期86-88,共3页 Clinical Medication Journal
关键词 重症急性胰腺炎 腹腔间隙综合征 抗感染治疗 severe acute pancreatitis abdominal compartment syndrome antibiotics therapies
  • 相关文献

参考文献7

二级参考文献47

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:241
  • 2赵玉沛.浅谈建立我国重症急性胰腺炎诊治指南的意义[J].中华外科杂志,2007,45(11):721-721. 被引量:22
  • 3张圣道,雷若庆.重症急性胰腺炎诊治指南[J].中华外科杂志,2007,45(11):727-729. 被引量:1148
  • 4中华人民共和国国家卫生和计划生育委员会.抗菌药物临床应用指导原则(2015年版)[M].北京:人民卫生出版社,2015.
  • 5Leclercq R, Canton R, Brown D F J, et al. EUCAST expert rutes in antimicrobial susceptibility testing [J]. Clin Microbiol Infect, 2013, 19(2): 141-160.
  • 6Pea F, Brollo L, Viale P, et al. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose [J]. J Antimicrob Chemother, 2003, 51(4): 941-945.
  • 7Chambers H F, Kennedy S. Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis [J]. Antimicrob Agents Chemother, 1990, 34 (4): 510-514.
  • 8Schentag J J. Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit [J]. Crit Care Med, 2001, 29(4): 100-110.
  • 9Weinbren M, Struthers K. Emergence of staphlococcus aureus(MRSA)with reduced susceptibility to teicoplanin during therapy[J]. J Antimicrob Chemother, 2002, 50(2):306-307.
  • 10Svetitsky S, Leibovici L, Paul M. Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis [J]. Antimicrob Agents Chemother, 2009, 53(10): 4069-4079.

共引文献1696

同被引文献33

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部